GUNA-IL 2
NDC 17089-380, ALDESLEUKIN, solution/ drops, from Guna spa.
- Product NDC
- 17089-380
- Status
- Listed
- Labeler
- Guna spa
- Dosage form
- SOLUTION/ DROPS
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17089-380 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALDESLEUKIN4 [hp_C]/30mL
Pharmacologic classes
Increased Lymphocyte Activation [PE]; Increased Lymphocyte Cell Production [PE]; Interleukin-2 [CS]; Lymphocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17089-380-18 | 17089038018 | 1 BOTTLE, DROPPER in 1 BOX (17089-380-18) / 30 mL in 1 BOTTLE, DROPPER |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 17089-380 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17089-380 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17089-380. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.